- Home
- LCTX vs EBMT Comparison
LCTX vs EBMT Comparison
Compare LCTX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- EBMT
- Stock Information
- Founded
- LCTX 1990
- EBMT 1922
- Country
- LCTX United States
- EBMT United States
- Employees
- LCTX N/A
- EBMT N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- EBMT Major Banks
- Sector
- LCTX Health Care
- EBMT Finance
- Exchange
- LCTX Nasdaq
- EBMT Nasdaq
- Market Cap
- LCTX 127.7M
- EBMT 139.5M
- IPO Year
- LCTX N/A
- EBMT N/A
- Fundamental
- Price
- LCTX $0.68
- EBMT $18.02
- Analyst Decision
- LCTX Strong Buy
- EBMT
- Analyst Count
- LCTX 4
- EBMT 0
- Target Price
- LCTX $4.50
- EBMT N/A
- AVG Volume (30 Days)
- LCTX 1.2M
- EBMT 29.0K
- Earning Date
- LCTX 03-06-2025
- EBMT 01-28-2025
- Dividend Yield
- LCTX N/A
- EBMT 3.16%
- EPS Growth
- LCTX N/A
- EBMT N/A
- EPS
- LCTX N/A
- EBMT 1.24
- Revenue
- LCTX $8,719,000.00
- EBMT $80,696,000.00
- Revenue This Year
- LCTX N/A
- EBMT N/A
- Revenue Next Year
- LCTX $41.15
- EBMT $6.33
- P/E Ratio
- LCTX N/A
- EBMT $14.53
- Revenue Growth
- LCTX N/A
- EBMT N/A
- 52 Week Low
- LCTX $0.48
- EBMT $12.32
- 52 Week High
- LCTX $1.61
- EBMT $18.37
- Technical
- Relative Strength Index (RSI)
- LCTX 53.39
- EBMT 78.44
- Support Level
- LCTX $0.58
- EBMT $14.87
- Resistance Level
- LCTX $0.73
- EBMT $15.47
- Average True Range (ATR)
- LCTX 0.05
- EBMT 0.54
- MACD
- LCTX 0.00
- EBMT 0.34
- Stochastic Oscillator
- LCTX 50.67
- EBMT 90.00
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.